ESTABLISHING A DRY EYE SUBSPECIALTY CLINIC

reviewlogo_2012

See this weeks Practice Pearl from Paul Karpecki, OD where he discusses the many diagnostic instruments he would like to include in his "dream dry eye practice". He mentions the TearLab Osmolarity System, among others. http://www.revoptom.com/email/010912_pearl86_v2.html … [Read more...]

The Evolving Role of Biomarkers

logo2

Biomarkers are becoming more and more important in patient care and this article by Elyse Chaglasian, OD presents multiple examples how eye care practitioners can care for their patients..... http://www.reviewofcontactlenses.com/content/c/31008/ … [Read more...]

The Advent of Tear Osmolarity

Dr.Lemp

The advent of tear osmolarity as a practical tool for diagnosis, determination of severity of disease and as a reliable objective measure of response to treatment is a game changer for clinicians faced daily in their offices with patients suffering from this disease. TearLab Corporation recently received a letter from the FDA … [Read more...]

TearLab Achieves Equal Reimbursement Across All States

December has turned out to be quite a month for TearLab Corporation. TearLab achieved their largest milestone last week when they received FDA communication granting them the CLIA waiver for the TearLab® Osmolarity System (pending labeling agreements). In addition, in a press release on Tuesday of this week, TearLab announced … [Read more...]

TearLab Published in AAO Preferred Practice Patterns

Dr.Lemp

The American Academy of Ophthalmology in September published a partial revision of the Preferred Practice Patterns for Dry Eye. In this, tear osmolarity was added to the recommended diagnostic tests for dry eye disease and specifically the TearLab was referenced. This recognition by the Academy’s panel of the critical role tear … [Read more...]

In My Practice : Marguerite B. McDonald, MD, FACS

mm

Dr. McDonald is the Cornea/refractive/anterior segment specialist, Ophthalmic Consultants of Long Island, Lynbrook, NY. She is presently an Adjunct Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans and a Clinical Professor of Ophthalmology at New York University (NYU) in Manhattan. Dr … [Read more...]

FDA Grants TearLab® Osmolarity System CLIA Waiver Categorization

920095 Rev A tearlab web banner copy

CLIA Waiver status for the TearLab Osmolarity System (recently added to the American Academy of Ophthalmology Preferred Practice Pattern Guidelines) provides a unique opportunity for doctors to promote their practice with a specific focus for Dry Eye Disease Management.  Until now, the requirements to utilize the TearLab system … [Read more...]

TearLab continues to gain acceptance amongst thought leaders

logo

TearLab’s (NASDAQ:TEAR; TSX:TLB) osmolarity test for dry eye disease continues to make impressive inroads in gaining awareness and acceptance among U.S. eye doctors. TearLab Osmolarity Test For example, an article entitled “Tear Osmolarity in the Diagnosis and Management of Dry Eye Disease,” which appeared in the … [Read more...]

TearLab in My Practice – Sean Mulqueeny, OD

mulqueeny

Dr Sean Mulqueeny describes how he utilizes the TearLab Osmolarity System in his Dry Eye practice in an article in Optometric Management's September edition. Tear Test:  Osmolarity test quantifies tear film integrity Because the medical literature has shown tear osmolarity is a key indicator of tear film quality and can, … [Read more...]

Osmolarity: the one quantitative clinical endpoint

PCON

  Dr. David Sullivan, one of the world's leading experts in Ocular Surface Disease in a presentation in Boston at the OCRT AAO mtg said: "We have one clinical endpoint that happens to be quantitative: osmolarity," Dr. Sullivan said. "We need more clinical endpoints; then it will be possible to develop a new treatment for … [Read more...]